HIV/에이즈 진단 시장 : 제품 유형, 검사 유형, 최종 사용자별 - 세계 예측(2025-2030년)

The HIV or AIDS Diagnostics Market was valued at USD 6.84 billion in 2023, expected to reach USD 7.46 billion in 2024, and is projected to grow at a CAGR of 9.12%, to USD 12.62 billion by 2030.

The HIV or AIDS diagnostics market encompasses the various tests and tools used to detect and monitor HIV infection, which includes antibody and antigen tests, viral load tests, CD4 tests, and others. The necessity of these diagnostics arises from the critical need for early detection and monitoring of HIV to enhance patient outcomes and prevent disease progression. Applications predominantly span healthcare settings, including hospitals, clinics, and diagnostic laboratories. End-use scope extends to research institutes focusing on the development of enhanced diagnostic technologies. Market growth is significantly influenced by increased awareness of the importance of early HIV detection, a rise in global HIV prevalence, and advancements in technology that enable quicker and more accurate testing. Emerging opportunities lie in areas like point-of-care testing, which provides rapid results, critical in resource-limited settings. The rise of digital health and telemedicine presents an opportunity to integrate mobile diagnostics for wider accessibility. However, the market faces limitations, such as stigma associated with HIV testing, regulatory hurdles, and the high cost of advanced diagnostic methods, which can impede widespread adoption. Innovation is ripe in areas such as the development of low-cost, rapid tests, and integration of artificial intelligence for interpretative accuracy and predictive analytics in HIV diagnostics. For business growth, companies are recommended to invest in expanding testing accessibility, especially in underserved areas, and in developing cost-effective diagnostic solutions. The market is characterized by continuous research and development efforts, with a trend towards personalized medicine and precision diagnostics. While the potential is significant, maintaining rigorous quality and ethical standards will be crucial in navigating the competitive landscape and achieving sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving HIV or AIDS Diagnostics Market

The HIV or AIDS Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing government initiatives for HIV awareness
  • Prevalence of HIV among population worldwide
  • High preference for Nucleic acid tests
• Market Restraints
  • High cost of Nucleic acid tests (NAT)
• Market Opportunities
  • Advanced diagnostic methods exploring new ways of treatment
  • Innovative technologies for early infant diagnosis of HIV
• Market Challenges
  • Concerns related to inaccurate test results

Porter's Five Forces: A Strategic Tool for Navigating the HIV or AIDS Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the HIV or AIDS Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the HIV or AIDS Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the HIV or AIDS Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the HIV or AIDS Diagnostics Market

A detailed market share analysis in the HIV or AIDS Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the HIV or AIDS Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the HIV or AIDS Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the HIV or AIDS Diagnostics Market

A strategic analysis of the HIV or AIDS Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the HIV or AIDS Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alere Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Chembio Diagnostic Systems Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc., OraSure Technologies, Inc., and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the HIV or AIDS Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Instruments and Kits & Reagents.
• Based on Test Type, market is studied across ELISA, Nucleic Acid Tests, and Rapid Tests.
• Based on End User, market is studied across Academic & Research Institutes, Hospitals, and Private Diagnostics Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing government initiatives for HIV awareness
    • 5.1.1.2. Prevalence of HIV among population worldwide
    • 5.1.1.3. High preference for Nucleic acid tests
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of Nucleic acid tests (NAT)
  • 5.1.3. Opportunities
    • 5.1.3.1. Advanced diagnostic methods exploring new ways of treatment
    • 5.1.3.2. Innovative technologies for early infant diagnosis of HIV
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns related to inaccurate test results
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. HIV or AIDS Diagnostics Market, by Product Type

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Kits & Reagents

7. HIV or AIDS Diagnostics Market, by Test Type

• 7.1. Introduction
• 7.2. ELISA
• 7.3. Nucleic Acid Tests
• 7.4. Rapid Tests

8. HIV or AIDS Diagnostics Market, by End User

• 8.1. Introduction
• 8.2. Academic & Research Institutes
• 8.3. Hospitals
• 8.4. Private Diagnostics Laboratories

9. Americas HIV or AIDS Diagnostics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific HIV or AIDS Diagnostics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa HIV or AIDS Diagnostics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Alere Inc.
• 3. Becton Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. Chembio Diagnostic Systems Inc.
• 6. Danaher Corporation
• 7. F. Hoffmann-La Roche Ltd.
• 8. Hologic, Inc.
• 9. OraSure Technologies, Inc.
• 10. Siemens Healthineers AG